- Home
- UGI vs RGEN Comparison
UGI vs RGEN Comparison
Compare UGI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGI
- RGEN
- Stock Information
- Founded
- UGI 1940
- RGEN 1981
- Country
- UGI United States
- RGEN United States
- Employees
- UGI N/A
- RGEN N/A
- Industry
- UGI Natural Gas Distribution
- RGEN Medical/Dental Instruments
- Sector
- UGI Utilities
- RGEN Health Care
- Exchange
- UGI Nasdaq
- RGEN Nasdaq
- Market Cap
- UGI 6.9B
- RGEN 8.0B
- IPO Year
- UGI N/A
- RGEN N/A
- Fundamental
- Price
- UGI $34.54
- RGEN $128.04
- Analyst Decision
- UGI Buy
- RGEN Buy
- Analyst Count
- UGI 2
- RGEN 12
- Target Price
- UGI $27.50
- RGEN $172.67
- AVG Volume (30 Days)
- UGI 2.1M
- RGEN 830.2K
- Earning Date
- UGI 05-07-2025
- RGEN 04-29-2025
- Dividend Yield
- UGI 4.34%
- RGEN N/A
- EPS Growth
- UGI N/A
- RGEN N/A
- EPS
- UGI 2.46
- RGEN N/A
- Revenue
- UGI $7,318,000,000.00
- RGEN $650,429,000.00
- Revenue This Year
- UGI $6.20
- RGEN $13.93
- Revenue Next Year
- UGI $8.02
- RGEN $14.35
- P/E Ratio
- UGI $14.01
- RGEN N/A
- Revenue Growth
- UGI N/A
- RGEN 4.88
- 52 Week Low
- UGI $22.01
- RGEN $102.97
- 52 Week High
- UGI $34.49
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- UGI 64.54
- RGEN 44.98
- Support Level
- UGI $34.32
- RGEN $123.10
- Resistance Level
- UGI $35.35
- RGEN $135.47
- Average True Range (ATR)
- UGI 0.67
- RGEN 6.85
- MACD
- UGI 0.17
- RGEN -0.74
- Stochastic Oscillator
- UGI 74.86
- RGEN 19.54
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.